51 Results for "

P16

" in MedChemExpress (MCE) Product Catalog:
Products (51)

51 Results for "P16" in MCE Product Catalog:

Cat. No.: HY-P88881A
Synonyms: ARF; CDK4I; CDKN2; CMM2; INK4; INK4A; MLM; MTS-1; MTS1; P14; P14ARF; P16; P16-INK4A; P16INK4

Host:  

Mouse

Application:  

IHC-P, FC

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-115569
CAS No.: 1966107-70-9
Target:  

G-quadruplex c-Myc

Research Areas:  

Cancer

DC-34 is a selective stabilizer of MYC G-quadruplexes (G4s), with measured Kd values of 9.4 μM (FIA), 1.4 μM (SPR), and 16.5 μM (NMR) across different assays. DC-34 downregulates MYC levels in cancer cells in a G4-dependent manner, reduces cell viability, and induces G0-G1 cell cycle arrest and p16-marked senescence in MYC-driven multiple myeloma cells. DC-34 can serve as a probe for G4-dependent gene regulation studies and is applicable to research on multiple myeloma .
loading...
    loading...
Cat. No.: HY-183456
CAS No.: 71308-35-5
Tyrphostin AG17 is an orally active CDK2 inhibitor and EGFR tyrosine kinase antagonist. Tyrphostin AG17 reduces the levels of p21 and p16. Tyrphostin AG17 induces G1 phase cell cycle arrest, Apoptosis, mitochondrial dysfunction, decreased ATP levels, and inhibits DNA, RNA and protein synthesis, adipogenesis, and lipid synthesis. Tyrphostin AG17 inhibits fat accumulation, white adipose tissue hypertrophy, and alterations of glycogen and lipid inclusions in hepatocytes in obese mice without changing their serum biochemical parameters. Tyrphostin AG17 exhibits anticancer effects. Tyrphostin AG17 can be used in research related to immunoblastic lymphoma, leukemia, ovarian cancer, glioblastoma, colon cancer, breast cancer, melanoma, obesity and hepatic steatosis .
loading...
    loading...
Cat. No.: HY-168895A
CAS No.: 3125025-29-5
Target:  

Drug Isomer

Research Areas:  

Cancer

(E,E)-c-Fos-IN-1 is the active stereoisomer of c-Fos-IN-1 (HY-168895) in which both double bonds are in the trans configuration. c-Fos-IN-1 (Compound P16) is a c-Jun inhibitor, and decreases mRNA levels and protein levels of c-Fos. c-Fos-IN-1 also inhibits the phosphorylation activity of ERK and the transcriptional activity of AP-1. c-Fos-IN-1 shows anticancer activity by inhibiting ERK/c-Fos/Jun pathway. c-Fos-IN-1 inhibits the proliferation and migration of gastric cancer cells (IC50: 2.31 μM for MGC-803 cell). c-Fos-IN-1 arrests cell cycle at G2/M phase and induces cancer cell apoptosis. c-Fos-IN-1 inhibits gastric cancer tumor growth .
loading...
    loading...
Cat. No.: HY-P76353
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: GABARAPL2; Golgi-Associated ATPase Enhancer Of 16 KDa; GABA Type A Receptor Associated Protein Like 2; General Protein Transport Factor P16; GATE-16; Ganglioside Expression Factor 2; GEF2; GEF-2; GATE16; GABA(A) Receptor-Associated Protein-Like 2, Isoform
Species:  
Human
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-185751
CAS No.: 2760467-77-2
Target:  

Liposome

Research Areas:  

Cancer

10A1P16 is an ionizable phospholipid composed of a tertiary amine, a phosphate group and three hydrophobic tails. As a spleen-selective RNA delivery vector, 10A1P16 successfully transfects approximately 30% of splenic macrophages and 6% of splenic B cells in vivo. 10A1P16 can be used to prepare spleen-selective 10A1P16-MDOA lipid nanoparticles, which effectively mediate mRNA delivery and gene editing in mouse models. This delivery system retains potent spleen-targeted mRNA delivery efficacy and can be applied to ovarian cancer research .
loading...
    loading...
Cat. No.: HY-177978
CAS No.: 174062-72-7
Target:  

Endogenous Metabolite

Research Areas:  

Infection

LysoPE(P-16:0/0:0) is a lysophosphatidylethanolamine and metabolite. LysoPE(P-16:0/0:0) is significantly decreased in the plasma of spinal tuberculosis. LysoPE(P-16:0/0:0) can be screened as potential diagnostic biomarkers for spinal tuberculosis .
loading...
    loading...
Cat. No.: HY-185128
CAS No.: 802981-98-2
Synonyms: PlsEtn 16:0/18:2
Target:  

Endogenous Metabolite

Research Areas:  

Neurological Disease Endocrinology

PE (P-16:0/18:2(9Z,12Z)) (PlsEtn 16:0/18:2) is a phosphatidylethanolamine that can be used as a metabolic biomarker for evaluating uterine muscle layer infiltration and Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-N11605
CAS No.: 65877-71-6
Synonyms: PC(P-16:0/18:1(9Z))
loading...
    loading...
Cat. No.: HY-148965A
Synonyms: DPPI-3-P ammonium; PIP[3'](16:0/16:0) ammonium; PI(3)P (16:0/16:0) ammonium
Research Areas:  

Others

PtdIns-(3)-P1 (1,2-dipalmitoyl) (Compound 7) ammonium is a derivative of phosphatidylinositol 3-phosphate (PtdIns(3)P). phosphatidylinositol 3-phosphate can bind to the FYVE domain of human EEA1 and act as a second messenger in cellular signaling and membrane trafficking. phosphatidylinositol 3-phosphate can stimulate ROS formation by regulating the neutrophil oxidase complex .
loading...
    loading...
Cat. No.: HY-L077
4,336 compounds

Pancreatic cancer is a devastating disease with a low overall survival rate. Chemotherapy is the most common treatment for patients presenting with advanced pancreatic cancer. More recently, the era of targeted therapies has generated a lot of interest in discovering better approaches for patients with pancreatic cancer. Commonly mutated genes in pancreatic cancer include K-ras (in 74-100% of cases), p16INK4a (up to 98%), p53 (43 to 76%), DPC4 (about 50%), HER-2/neu (in about 65%) and FHIT (found in 70% of cases). Other genes involved are notch1, Akt-2, BRCA2 and COX-2. These proteins are important targets of target therapies for pancreatic cancer.

MCE offers a unique collection of 4,336 compounds with identified and potential anti- pancreatic cancer activity. These compounds target K-Ras, p53, HER2, Notch, AKT, etc. MCE anti-pancreatic cancer compound library is a useful tool for anti-pancreatic cancer drugs screening and other related research.